Case report
Open access
Sep 2026
Combining Pembrolizumab and Ofatumumab in Triple-Negative Breast Cancer and Multiple Sclerosis: A Case Report
ABSTRACT INTRODUCTION Pembrolizumab has been widely used since its approval as perioperative therapy for triple-negative breast cancer. While the emergence of diverse antibody drugs has expanded therapeutic options in recent years, reports on the combined use of immune-related antibodies in patients with other diseases...
Haruna Iriyama, M. Iwase, Yuko Takano et al.
· Surgery Case Reports · 0 citations